Histopathological Imaging–Environment Interactions in Cancer Modeling
AbstractHistopathological imaging has been routinely conducted in cancer diagnosis and recently used for modeling other cancer outcomes/phenotypes such as prognosis. Clinical/environmental factors have long been extensively used in cancer modeling. However, there is still a lack of study exploring possible interactions of histopathological imaging features and clinical/environmental risk factors in cancer modeling. In this article, we explore such a possibility and conduct both marginal and joint interaction analysis. Novel statistical methods, which are “borrowed” from gene–environment interaction analysis, are employed. Analysis of The Cancer Genome Atlas (TCGA) lung adenocarcinoma (LUAD) data is conducted. More specifically, we examine a biomarker of lung function as well as overall survival. Possible interaction effects are identified. Overall, this study can suggest an alternative way of cancer modeling that innovatively combines histopathological imaging and clinical/environmental data. View Full-Text
Share & Cite This Article
Xu, Y.; Zhong, T.; Wu, M.; Ma, S. Histopathological Imaging–Environment Interactions in Cancer Modeling. Cancers 2019, 11, 579.
Xu Y, Zhong T, Wu M, Ma S. Histopathological Imaging–Environment Interactions in Cancer Modeling. Cancers. 2019; 11(4):579.Chicago/Turabian Style
Xu, Yaqing; Zhong, Tingyan; Wu, Mengyun; Ma, Shuangge. 2019. "Histopathological Imaging–Environment Interactions in Cancer Modeling." Cancers 11, no. 4: 579.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.